Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries

Documenti analoghi

• Evaluation of Interstitial Lung Disease Complications Caused by Biologic Agents Using a Spontaneous Adverse Drug Reaction Reporting Database
  di: Ayu Minagi, et al.
  Pubblicazione: (2025)
• Analysis of Reporting Trends of Serious Adverse Events Associated With Anti‐Obesity Drugs
  di: Branislava B. Raičević, et al.
  Pubblicazione: (2025)
• Hiffmax Motor Company
  di: Yan Jin, et al.
  Pubblicazione: (2025)
• Pharmacoepidemiology of Oxycodone in the USA: An Observational Study of ARCOS, Medicaid, and Medicare Drug Databases
  di: Jay P. Solgama, et al.
  Pubblicazione: (2026)
• Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction
  di: Laura Patanè, et al.
  Pubblicazione: (2025)